全文获取类型
收费全文 | 96322篇 |
免费 | 7317篇 |
国内免费 | 299篇 |
专业分类
耳鼻咽喉 | 1054篇 |
儿科学 | 2676篇 |
妇产科学 | 1439篇 |
基础医学 | 13346篇 |
口腔科学 | 1127篇 |
临床医学 | 10139篇 |
内科学 | 20771篇 |
皮肤病学 | 1118篇 |
神经病学 | 9651篇 |
特种医学 | 3627篇 |
外国民族医学 | 3篇 |
外科学 | 14981篇 |
综合类 | 1074篇 |
一般理论 | 98篇 |
预防医学 | 7052篇 |
眼科学 | 2609篇 |
药学 | 6174篇 |
中国医学 | 108篇 |
肿瘤学 | 6891篇 |
出版年
2023年 | 657篇 |
2022年 | 962篇 |
2021年 | 2599篇 |
2020年 | 1482篇 |
2019年 | 2431篇 |
2018年 | 2785篇 |
2017年 | 2012篇 |
2016年 | 2138篇 |
2015年 | 2472篇 |
2014年 | 3544篇 |
2013年 | 4556篇 |
2012年 | 7246篇 |
2011年 | 7531篇 |
2010年 | 4128篇 |
2009年 | 3645篇 |
2008年 | 6017篇 |
2007年 | 6362篇 |
2006年 | 5923篇 |
2005年 | 5840篇 |
2004年 | 5363篇 |
2003年 | 4881篇 |
2002年 | 4535篇 |
2001年 | 1195篇 |
2000年 | 986篇 |
1999年 | 1036篇 |
1998年 | 977篇 |
1997年 | 751篇 |
1996年 | 618篇 |
1995年 | 590篇 |
1994年 | 543篇 |
1993年 | 530篇 |
1992年 | 681篇 |
1991年 | 603篇 |
1990年 | 583篇 |
1989年 | 516篇 |
1988年 | 502篇 |
1987年 | 465篇 |
1986年 | 479篇 |
1985年 | 454篇 |
1984年 | 445篇 |
1983年 | 375篇 |
1982年 | 397篇 |
1981年 | 388篇 |
1980年 | 298篇 |
1979年 | 313篇 |
1978年 | 301篇 |
1977年 | 232篇 |
1976年 | 206篇 |
1974年 | 214篇 |
1973年 | 205篇 |
排序方式: 共有10000条查询结果,搜索用时 218 毫秒
1.
2.
3.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
4.
Triposkiadis Filippos Xanthopoulos Andrew Skoularigis John Starling Randall C. 《Heart failure reviews》2022,27(6):1991-2003
Heart Failure Reviews - The nitric oxide (NO)–guanylate cyclase (GC)–cyclic guanosine monophosphate (cGMP) pathway plays an important role in cardiovascular, pulmonary and renal... 相似文献
5.
Olga A. Klein Avril Drummond Jacqueline R. Mhizha-Murira Laura Mansford Roshan dasNair 《Neuropsychological rehabilitation》2019,29(4):491-512
While previous randomised controlled trials and meta-analyses offer only limited evidence for the effectiveness of cognitive rehabilitation, qualitative studies examining patient perspectives report more positive outcomes. This meta-synthesis of qualitative studies examined patient perspectives of cognitive rehabilitation for memory, attention, and executive function problems in people with multiple sclerosis. Using set eligibility criteria, we screened electronic databases, reference lists, and academic networks for relevant papers. Seven papers (195 participants) were selected. Two independent researchers conducted quality appraisals of papers. Data analysis, guided by the thematic synthesis approach, yielded six main themes. These suggested that patients benefitted from the group environment in rehabilitation. Cognitive rehabilitation facilitated the participants’ reflection and awareness of their cognitive deficits, and was associated with increased knowledge and understanding of their illness. Increased strategy use was reported and associated with improvements in cognitive functioning and greater confidence and perseverance. Participants reported emotional and social improvements, and felt more optimistic. Overall, these changes had a positive impact on participants’ quality of life. This synthesis of qualitative studies indicates that people with multiple sclerosis who experience cognitive deficits benefit from cognitive rehabilitation programmes. This finding must, however, be viewed in light of the limitations of this meta-synthesis. The meta-synthesis was registered in the PROSPERO database under CRD42017040148. 相似文献
6.
7.
Xin Yi Wong Andrew Qi Jun Lim Qianyu Shen John Whay Kuang Chia Min Hoe Chew Wah Siew Tan 《Current medical research and opinion》2020,36(10):1677-1686
Abstract
Objective
Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies. 相似文献8.
9.
10.
William R. C. Knight Cara R. Baker Nyree Griffin Wahyu Wulaningsih Mark Kelly Andrew R. Davies James A. Gossage 《British journal of cancer》2021,124(10):1653
Background A high Mandard score implies a non-response to chemotherapy in oesophageal adenocarcinoma. However, some patients exhibit tumour volume reduction and a nodal response despite a high score. This study examines survival and recurrence patterns in these patients.Methods Clinicopathological factors were analysed using multivariable Cox regression assessing time to death and recurrence. Computed tomography-estimated tumour volume change was examined in a subgroup of consecutive patients.Results Five hundred and fifty-five patients were included. Median survival was 55 months (Mandard 1–3) and 21 months (Mandard 4 and 5). In the Mandard 4 and 5 group (332 patients), comparison between complete nodal responders and persistent nodal disease showed improved survival (90 vs 18 months), recurrence rates (locoregional 14.75 vs 28.74%, systemic 24.59 vs 48.42%) and circumferential resection margin positivity (22.95 vs 68.11%). Complete nodal response independently predicted improved survival (hazard ratio 0.34 (0.16–0.74). Post-chemotherapy tumour volume reduction was greater in patients with a complete nodal response (−16.3 vs −7.7 cm3, p = 0.033) with no significant difference between Mandard groups.Conclusion Patients with a complete nodal response to chemotherapy have significantly improved outcomes despite a poor Mandard score. High Mandard score does not correspond with a non-response to chemotherapy in all cases and patients with nodal downstaging may still benefit from adjuvant chemotherapy.Subject terms: Oesophageal cancer, Surgical oncology 相似文献